Fingerprint
Dive into the research topics of 'AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer
Pasi A. Jänne*, James Chih-Hsin Yang, Dong Wan Kim, David Planchard, Yuichiro Ohe, Suresh S. Ramalingam, Myung Ju Ahn, Sang We Kim, Wu Chou Su, Leora Horn, Daniel Haggstrom, Enriqueta Felip, Joo Hang Kim, Paul Frewer, Mireille Cantarini, Kathryn H. Brown, Paul A. Dickinson, Serban Ghiorghiu, Malcolm Ranson
*Corresponding author for this work
- Dana-Farber Cancer Institute
- National Taiwan University Hospital
- Seoul National University Hospital
- Institut de Cancerlogie Gustave Roussy
- National Cancer Center Hospital
- Emory University
- Sungkyunkwan University
- Asan Medical Center
- National Cheng Kung University Hospital
- Vanderbilt-Ingram Cancer Center
- Carolinas HealthCare System
- Universitat Autonoma de Barcelona
- Yonsei University Health System
- AstraZeneca
Research output: Contribution to journal › Article › peer-review